NDC 72064-210

GAVRETO

Pralsetinib

GAVRETO is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Blueprint Medicines Corporation. The primary component is Pralsetinib.

• Product ID: 72064-210_16b2e8e7-2cd0-45f3-895b-62ccb7194b31
• NDC: 72064-210
• Product Type: Human Prescription Drug
• Proprietary Name: GAVRETO
• Generic Name: Pralsetinib
• Dosage Form: Capsule
• Route of Administration: ORAL
• Marketing Start Date: 2020-09-04
• Marketing Category: NDA / NDA
• Application Number: NDA213721
• Labeler Name: Blueprint Medicines Corporation
• Substance Name: PRALSETINIB
• Active Ingredient Strength: 100 mg/1
• NDC Exclude Flag: N
• Listing Certified Through: 2021-12-31

Packaging

NDC 72064-210-12

120 CAPSULE in 1 BOTTLE, PLASTIC (72064-210-12)

• Marketing Start Date: 2020-09-04
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "GAVRETO" or generic name "Pralsetinib"

NDC	Brand Name	Generic Name
50242-210	Gavreto	Pralsetinib
72064-210	GAVRETO	pralsetinib